Trials Sponsors Conditions Drugs Pricing

Conditions

Type 2 Diabetic Patients

Keywords

Dietary Approach to Stop HypertensionweightcoagulationDASH eating pattern.

Outcome Measures

Primary Outcomes (1)

Cardio-metabolic risks
6 months

Secondary Outcomes (1)

Hepatic function
6 months

Study Arms (2)

DASH diet

EXPERIMENTAL

DASH: Dietary approaches to stop hypertension eating plan

Dietary Supplement: DASH diet

Diabetic diet

PLACEBO COMPARATOR

Diabetic diet: a usual diabetic diet

Dietary Supplement: a usual diabetic diet

Interventions

DASH dietDietary supplement

Also known as: Dietary aproaches to stop hypertension

DASH diet

a usual diabetic dietDietary supplement

Diabetic diet

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age44 Years - 70 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Having type 2 diabetes

You may not qualify if:

Sponsors & Collaborators

Shahid Motahari Hospital of Fooladshahr, Isfahan Steel Company, Isfahan
Type not reportedcollaborator
Isfahan University of Medical Sciences
Otherlead

Study Sites (1)

Shahid motahari hospital, Esfahan Esteel company, Iran

Isfahan, Iran

Related Publications (1)

Azadbakht L, Surkan PJ, Esmaillzadeh A, Willett WC. The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J Nutr. 2011 Jun;141(6):1083-8. doi: 10.3945/jn.110.136739. Epub 2011 Apr 27.
PMID: 21525259DERIVED

MeSH Terms

Conditions

Body WeightThrombosis

Interventions

Dietary Approaches To Stop Hypertension

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDiet

Study Officials

Leila Azadbakht, PhD
Isfahan University of Medical Sciences
PRINCIPAL INVESTIGATOR

Enrollment

36 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 4
Allocation: RANDOMIZED
Masking: TRIPLE
Who Masked: CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose: TREATMENT
Intervention Model: CROSSOVER
Sponsor Type: OTHER

Study Record Dates

First Submitted

January 13, 2010

First Posted

January 14, 2010

Study Start

December 2008

Date type not reported

This date has not been verified as actual or estimated.

The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

DASH diet

Diabetic diet

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

DASH diet

Diabetic diet

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations